Laurion Capital Management LP Esperion Therapeutics, Inc. Transaction History

Laurion Capital Management LP

  • $5.23 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.2 - $1.76 $42,175 - $61,856
35,146 New
35,146 $48,000
Q4 2017

Feb 13, 2018
SELL
$43.47 - $67.43 $469,476 - $728,244
-10,800 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$43.8 - $52.77 $473,039 - $569,916
10,800
10,800 $541,000

Others Institutions Holding ESPR

# of Institutions
215
Shares Held
129M
Call Options Held
1.78M
Put Options Held
1.27M
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $126M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email